Ranbaxy integration to hit Sun Pharma, revenue, profit

Mumbai, (IANS) Drug major Sun Pharmaceutical Industries Ltd on Monday admitted that its consolidated revenue and profit for fiscal 2015-16 would be impacted by its integration with Ranbaxy Laboratories it bought for $3.2 billion last year.

“Post-acquisition, integration of Ranbaxy with our operations will adversely impact our overall revenues and profits for FY2016 due to expenses/charges arising out of it (integration),” Sun said in a statement here.

Sun bought the Indian multinational drug maker Ranbaxy from Daiichi Sankyo of Japan after nearly a year-long acquisition process that began in April 2014 and completed in March this year.

“As we expect to incur integration charges, consolidated revenue and profits will remain flat or decline over last fiscal,” the statement said.

The integration will generate long-term synergies from the merger though the company may discontinue non-strategic businesses.

“We have embarked on consolidation initiatives to drive growth and profitability by investing for future. We continue to strengthen and build leadership position in key markets and business segments,” Sun said in the statement.

The company has upped the target for the synergy benefits by 15-20 percent from its earlier target of $250 million by fiscal 2017-18.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here